(Q31522245)

2 July 2017

1 reference

title

Azimilide dihydrochloride: a new class III anti-arrhythmic agent (English)

1 reference

2 July 2017

R Abrol

1

1 reference

2 July 2017

R L Page

series ordinal

2

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

Expert Opinion on Investigational Drugs

2 July 2017

published in

1 reference

2 July 2017

volume

9

1 reference

2 July 2017

issue

11

1 reference

2 July 2017

page(s)

2705-2715

1 reference

Atrial fibrillation: a review of mechanism, etiology, and therapy

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

The seventh annual Gordon K. Moe Lecture. Atrial fibrillation: from cell t bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Cellular electropharmacology of amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Evidence-based analysis of amiodarone efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Azimilide causes reverse rate-dependent block while reducing both components of delayed-rectifier current in canine ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

Effect of age and gender on azimilide pharmacokinetics after a single oral dose of azimilide dihydrochloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.11.2705

10.1517/13543784.9.11.2705

21 January 2018

Identifiers

DOI

1 reference

2 July 2017

1 reference